Brooklyn ImmunoTherapeutics Announces Receipt of Nasdaq
SAN DIEGO, June 17, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn” or the “Company”), a biopharmaceutical company...
Michaelv Morabito Brooklyn Immunotherapeutics Exchange Commission Nasdaq Stock Market Securities Exchange Brooklyn Immunotherapeutics Inc
Source: globenewswire.com